Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $4.03 Analyst target: $124.25 Upside: 2983.13%
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics for the prevention and treatment of disease. The company is headquartered in New York, New York.
See the full interactive analysis & chart →Informational only — not investment advice.